
Last updated: 2026-10-05 13:40:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Alector, Inc. (ALEC) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $2,23, with a market capitalisation of $202,10M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1,09 to $3,40. This page covers its latest market performance, valuation, price trends and company information.
$202,10M | |
$1,82 | |
$43,32 | |
$0,87 | |
$1,81 | |
55,65M | |
1,18M | |
-- | |
$3,40 | |
$1,09 | |
-- | |
-- |
Alector, Inc. (ALEC) is currently trading at $2,23 as of 2026-10-05 13:24:53, up 22,98% ($0,42) from the previous close of $1,81
During today's regular trading session, ALEC has traded between $0,87 and $43,32, with a trading volume of 55,65M shares. The current price is near the lower end of today's range.
Over the past seven days, Alector, Inc. (ALEC) moved from $1,92 to $2,23, representing a gain of 15,94% ($0,31).
The stock traded between $1,80 and $3,21 during the period. The latest price is near the lower end of the 7-day range, indicating strong upward.
The average daily volume was 898,06 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 49,2%
ALEC is currently trading at $2,23, placing it 49,2% of the way from its 52-week low of $1,09 to its 52-week high of $3,40. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 103 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Alector, Inc. (ALEC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.